Instrumento Inactivo

Otros idiomas Provention Bio, Inc.

Acciones

PRVB

US74374N1028

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P Pharmaceuticals Select Industry Index	02/05/23
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P Global BMI Index	02/05/23
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P TMI Index	02/05/23
Improving Confidence in Eurozone Economy Lifts French Shares Amid Q1 Results Outpour	27/04/23
Sanofi Completes Provention Bio Acquisition	27/04/23
Sanofi : acquisition de Provention Bio finalisée	27/04/23
Sanofi : finalise l'acquisition de l'américain Provention Bio	27/04/23
Provention Bio : Termination of Material Agreement - Form 8-K	27/04/23
PROVENTION BIO, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	27/04/23
Provention Bio, Inc. Appoints Debora Pellicano as Chief Financial Officer	27/04/23
Provention Bio, Inc. Announces Management Changes	27/04/23
Sanofi a finalisé l'acquisition de la biotech américaine Provention Bio	27/04/23
Sanofi Closes $3 Billion Acquisition of Provention Bio	27/04/23
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from NASDAQ Composite Index	27/04/23
Sanofi completed the acquisition of 97.1% stake in Provention Bio, Inc..	27/04/23
Sanofi : période d'attente expirée pour Provention Bio	26/04/23
Sanofi Secures US Antitrust Clearance for $2.9 Billion Provention Bio Takeover	26/04/23
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from NASDAQ Biotechnology Index	26/04/23
Sanofi wins US drug control from AstraZeneca in Sobi deal	11/04/23
Sanofi Extends Offer Period for Provention Bio Takeover Amid US Regulatory Review	11/04/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Provention Bio, Inc.

Acciones

PRVB

US74374N1028

Otros idiomas

Filtros